Neurogene Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $103.8M | $136.6M | $148.2M | $82.0M | $142.5M | $192.6M | $143.1M | $76.9M |
| Accounts Receivable | — | — | — | — | — | — | — | — |
| Inventory | — | — | — | — | — | — | — | — |
| Total Current Assets | $271.8M | $315.9M | $200.3M | $84.7M | $144.0M | $194.5M | $143.6M | $77.2M |
| Property, Plant & Equipment | $12.8M | $15.4M | $17.2M | $20.1M | — | $3.6M | $2.1M | $400.0K |
| Goodwill | — | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | $0 | $128.0K | $347.0K | $567.0K | — |
| Total Assets | $288.6M | $335.7M | $222.6M | $109.3M | $163.3M | $210.5M | $147.0M | $77.6M |
| Liabilities | ||||||||
| Accounts Payable | $2.0M | $1.3M | $2.6M | $625.0K | $526.0K | $1.3M | $1.6M | $702.0K |
| Total Current Liabilities | $16.4M | $15.2M | $23.0M | $6.7M | $8.6M | $7.9M | $4.7M | $4.6M |
| Long-Term Debt | — | — | — | — | — | — | — | — |
| Total Liabilities | $23.7M | $25.4M | $36.5M | $10.6M | $20.4M | $19.3M | $5.3M | $4.9M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-352.6M | $-262.3M | $-187.2M | $-150.8M | $-393.5M | $-332.8M | $-299.5M | $-230.1M |
| Total Stockholders' Equity | $264.9M | $310.4M | $186.0M | $-145.7M | $-91.9M | $191.2M | $141.7M | $72.7M |